Ty S. Schepis

3.2k total citations
106 papers, 2.3k citations indexed

About

Ty S. Schepis is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Ty S. Schepis has authored 106 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 38 papers in Epidemiology and 30 papers in Psychiatry and Mental health. Recurrent topics in Ty S. Schepis's work include Opioid Use Disorder Treatment (40 papers), Substance Abuse Treatment and Outcomes (38 papers) and Attention Deficit Hyperactivity Disorder (29 papers). Ty S. Schepis is often cited by papers focused on Opioid Use Disorder Treatment (40 papers), Substance Abuse Treatment and Outcomes (38 papers) and Attention Deficit Hyperactivity Disorder (29 papers). Ty S. Schepis collaborates with scholars based in United States, Norway and Ireland. Ty S. Schepis's co-authors include Sean Esteban McCabe, Suchitra Krishnan‐Sarin, Christian J. Teter, Uma Rao, Jason A. Ford, Jahn K. Hakes, Carol J. Boyd, Timothy E. Wilens, Dana A. Cavallo and Thomas Liss and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Ty S. Schepis

94 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ty S. Schepis United States 32 817 814 551 477 423 106 2.3k
Theresa Winhusen United States 28 764 0.9× 861 1.1× 370 0.7× 477 1.0× 410 1.0× 132 2.6k
Alex Baldacchino United Kingdom 25 651 0.8× 625 0.8× 530 1.0× 279 0.6× 256 0.6× 111 2.2k
Iván D. Montoya United States 30 662 0.8× 1.0k 1.3× 571 1.0× 303 0.6× 372 0.9× 71 2.5k
Maureen Hillhouse United States 31 1.6k 1.9× 1.7k 2.0× 379 0.7× 509 1.1× 480 1.1× 71 3.0k
Michael Kidorf United States 32 992 1.2× 1.5k 1.8× 505 0.9× 214 0.4× 242 0.6× 84 2.3k
Gregory S. Brigham United States 23 617 0.8× 845 1.0× 537 1.0× 225 0.5× 216 0.5× 41 2.0k
Victoria R. Votaw United States 18 401 0.5× 683 0.8× 466 0.8× 230 0.5× 255 0.6× 51 1.8k
Mélina Fatseas France 26 567 0.7× 708 0.9× 588 1.1× 144 0.3× 219 0.5× 91 2.0k
Susan C. Sonne United States 32 404 0.5× 949 1.2× 1.2k 2.2× 349 0.7× 542 1.3× 63 3.3k
Stacey C. Sigmon United States 32 1.5k 1.8× 1.3k 1.6× 296 0.5× 495 1.0× 326 0.8× 117 2.9k

Countries citing papers authored by Ty S. Schepis

Since Specialization
Citations

This map shows the geographic impact of Ty S. Schepis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ty S. Schepis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ty S. Schepis more than expected).

Fields of papers citing papers by Ty S. Schepis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ty S. Schepis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ty S. Schepis. The network helps show where Ty S. Schepis may publish in the future.

Co-authorship network of co-authors of Ty S. Schepis

This figure shows the co-authorship network connecting the top 25 collaborators of Ty S. Schepis. A scholar is included among the top collaborators of Ty S. Schepis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ty S. Schepis. Ty S. Schepis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holt, Laura J., Alison Looby, Richard Feinn, & Ty S. Schepis. (2025). Preventing Prescription Stimulant Diversion and Misuse via a Web-Based Intervention: A Randomized Controlled Trial. PsyArXiv (OSF Preprints).
2.
Schepis, Ty S., et al.. (2025). Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.. Experimental and Clinical Psychopharmacology. 33(3). 275–284.
3.
Blair, Lisa M., et al.. (2024). The substance use disorder treatment gap among US college students: Findings from the 2021 National Survey on Drug Use and Health. Drug and Alcohol Dependence Reports. 12. 100279–100279. 3 indexed citations
4.
McCabe, Sean Esteban, Vita V. McCabe, Ty S. Schepis, et al.. (2023). Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?. Journal of Child Psychology and Psychiatry. 65(1). 100–111. 12 indexed citations
5.
Ford, Jason A., Sean Esteban McCabe, & Ty S. Schepis. (2023). Prescription Drug Misuse with Alcohol Coingestion among US Adolescents: Youth Experiences, Health-related Factors, and Other Substance Use Behaviors. Journal of Addiction Medicine. 17(4). 379–386. 2 indexed citations
6.
7.
Schepis, Ty S., et al.. (2023). Posttraumatic stress disorder in diverse populations: Testing for assessment bias in a nationally representative sample.. Psychological Trauma Theory Research Practice and Policy. 16(8). 1252–1259.
8.
McCabe, Sean Esteban, John E. Schulenberg, Timothy E. Wilens, et al.. (2023). Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence. JAMA Network Open. 6(7). e2322650–e2322650. 8 indexed citations
9.
McCabe, Sean Esteban, John E. Schulenberg, Timothy E. Wilens, et al.. (2023). Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020. JAMA Network Open. 6(4). e238707–e238707. 14 indexed citations
10.
Holt, Laura J., et al.. (2022). Sources for prescription stimulant misuse: A person-centered approach to understanding links to substance use and psychiatric impairment.. Experimental and Clinical Psychopharmacology. 31(2). 498–506. 2 indexed citations
11.
12.
Looby, Alison, Mark A. Prince, Margo C. Hurlocker, et al.. (2021). Young adult use, dual use, and simultaneous use of alcohol and marijuana: An examination of differences across use status on marijuana use context, rates, and consequences.. Psychology of Addictive Behaviors. 35(6). 682–690. 37 indexed citations
13.
Schepis, Ty S., et al.. (2020). Prescription Tranquilizer/Sedative Misuse Motives Across the US Population. Journal of Addiction Medicine. 15(3). 191–200. 10 indexed citations
14.
Holt, Laura J., et al.. (2019). How to say “no” most effectively: Evaluating resistance strategies for prescription stimulant diversion to inform preventive interventions. Journal of American College Health. 68(8). 872–882. 4 indexed citations
15.
McCabe, Sean Esteban, Timothy E. Wilens, Carol J. Boyd, et al.. (2018). Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States. Addictive Behaviors. 90. 285–293. 40 indexed citations
16.
Morean, Meghan E., Deepa R. Camenga, Grace Kong, et al.. (2014). Predictors of Middle School Students’ Interest in Participating in an Incentive-Based Tobacco Prevention and Cessation Program in Connecticut. SHILAP Revista de lepidopterología. 2014. 1–6. 11 indexed citations
17.
18.
Schepis, Ty S. & Sean Esteban McCabe. (2011). Exploring age of onset as a causal link between major depression and nonmedical use of prescription medications. Drug and Alcohol Dependence. 120(1-3). 99–104. 15 indexed citations
19.
Cavallo, Dana A., Charla Nich, Ty S. Schepis, et al.. (2010). Preliminary Examination of Adolescent Spending in a Contingency Management-Based Smoking-Cessation Program. Journal of Child & Adolescent Substance Abuse. 19(4). 335–342. 5 indexed citations
20.
Adinoff, Bryon, et al.. (2007). Impulsivity, Neural Deficits, and the Addictions. Journal of Addictive Diseases. 26(sup1). 25–39. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa Winhusen Breakdown of academic impact, for papers by Alex Baldacchino Breakdown of academic impact, for papers by Iván D. Montoya Breakdown of academic impact, for papers by Maureen Hillhouse Breakdown of academic impact, for papers by Michael Kidorf Breakdown of academic impact, for papers by Gregory S. Brigham Breakdown of academic impact, for papers by Victoria R. Votaw Breakdown of academic impact, for papers by Mélina Fatseas Breakdown of academic impact, for papers by Susan C. Sonne Breakdown of academic impact, for papers by Stacey C. Sigmon
Rankless by CCL
2026